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FGFhesion molecule expression and participates in speciﬁcation of tooth-types, but
little is understood of its role in patterning the pharyngeal arches. We examined barx1 expression during
zebraﬁsh craniofacial development and performed a functional analysis using antisense morpholino
oligonucleotides. Barx1 is expressed in the rhombencephalic neural crest, the pharyngeal arches, the pectoral
ﬁn buds and the gut in contrast to its paralogue barx2, which is most prominently expressed in the arch
epithelium. Additionally, barx1 transient expression was observed in the posterior lateral line ganglia and
developing trunk/tail. We show that Barx1 is necessary for proliferation of the arch osteochondrogenic
progenitors, and that morphants exhibit diminished and dysmorphic arch cartilage elements due to
reductions in chondrocyte differentiation and condensation. Attenuation of Barx1 results in lost arch
expression of osteochondrogenic markers col2a1, runx2a and chondromodulin, as well as odontogenic marker
dlx2b. Further, loss of barx1 positively inﬂuenced gdf5 and chordin, markers of jaw joint patterning. FGF
signaling is required for maintaining barx1 expression, and that ectopic BMP4 induces expression of barx1 in
the intermediate region of the second pharyngeal arch. Together, these results indicate an essential role for
barx1 at early stages of chondrogenesis within the developing zebraﬁsh viscerocranium.
Published by Elsevier Inc.Introduction
The viscerocranium consists of highly adapted skeletal elements
derived from the embryonic pharyngeal arch ectomesenchyme that
function in concert but allow for diverse pharyngolaryngeal activities.
The viscerocranium is composed of membranous and endochondral
bones. Endochondral bone formation within the pharyngeal arches is
a multi-step process that requires the migration of the cranial neural
crest into the facial prominences and their subsequent epitheliome-
senchymal interactions; these interactions are necessary for fate
determination, aggregation of the cells into discrete condensations,
and their terminal differentiation (Hall and Miyake, 2000; Helms and
Schneider, 2003; Goldring et al., 2006). Signaling factors that include
Bone Morphogenic Proteins (BMPs) and Fibroblast Growth Factors
(FGFs), through reciprocal epitheliomesenchymal interactions, inﬂu-
ence the expression of downstream factors that pattern the
chondrogenic elements (de Crombrugghe et al., 2000; Hall and
Miyake, 2000; Tuan, 2004; Goldring et al., 2006). The precise
mechanism of patterning osteochondrogenic progenitors is not well
understood.000 Rockville Pike, National
x: +1 301 496 0243.
).
nc.The Barx family of homeodomain-containing transcription factors
participates in the formation of mesenchymal condensations through
the modulation of cellular adhesion molecules (CAMs), and regulation
ofﬁbril-forming type II collagen (Col2a1) (Jones et al.,1997; Edelman et
al., 2000; Meech et al., 2005). The regulation of CAMs and Col2a1, a
major component of the cartilage extracellular matrix, by Barx1
indicates a direct link between expression of a tissue-speciﬁc
transcription factor and changes in cartilage morphology. In the
mouse, Barx1 expression is located at sites of mesenchymal condensa-
tion that include the pharyngeal arches, the limb buds, developing
joints, molar tooth papillae and the stomach wall (Tissier-Seta et al.,
1995; Jones et al., 1997; Barlow et al., 1999; Kim et al., 2005). Ectopic
Barx1 gene expression in mouse mandible cultures results in the
alteration of incisor teeth to an unusual molariform shape (Tucker et
al., 1998; Miletich et al., 2005), while attenuation of Barx1 by RNA
interference results in arrest of molar mesenchyme at the bud stage
(Song et al., 2006). Manipulation of the closely related Barx2 gene
expression in limb bud cultures affects cellular aggregation and
chondrocyte differentiation, indicating a familial role in patterning
chondrocytes (Meech et al., 2005). The function of Barx1 in craniofacial
development has yet to be fully examined. In humans, rare duplica-
tions and deletions of the BARX1 locus result in craniofacial and joint
anomalies, but no disease-causing mutations have been associated
directly with this gene (Stalker et al., 1993; Gould and Walter, 2000;
Fig. 1. Molecular analysis of zebraﬁsh barx1. (A) The coding region of barx1 consists of
four exons (boxes, numbered with Roman numerals) containing the homeobox (HB,
blue) and the Bar Basic Region (BBR, green); UTR's are indicated by outlined boxes.
Target sites of the barx1 ATG morpholino (Bx MO) and the splice-acceptor site
morpholino (Sa MO) are indicated. (B) Phylogenetic tree comparing zebraﬁsh (z) Barx1
with the human (h), mouse (m), and chicken (c) Barx amino acid sequences, as
examined using ClustalW. GenBank accession nos.: (h1) NM021570, (m1) NM007526,
(c1) NM204193, (z1) NM001024949, (h2) NM003658, (m2) NM013800, (c2) NM204896,
(z2) XM001342008 respectively. (C) Syntenic relationship between zebraﬁsh chromo-
some 11 fragment contig: CR548622.8 (Ensembl release 49, March 2008) and the
human chromosome 9q22.32 (loci distances indicated in Mb). The barx1 and phf2, PHD
ﬁnger protein 2, are linked in zebraﬁsh and humans.
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ship of this gene with craniofacial development we characterized
zebraﬁsh barx1 and the phenotype on the barx1morphant.
Here we show that the zebraﬁsh barx1 gene is expressed in the
migrating cranial neural crest and subsequently in the developing
cartilage elements of the pharyngeal arches. Transient expression is
observed in the posterior lateral line ganglia and in the trunk and tail.
In contrast to barx1, the barx2 paralogue is expressed predominantly
in the proximal aspects of the ﬁn buds and in oral and aboral
epithelium of the ﬁrst and second pharyngeal arches. Attenuation of
barx1 expression using antisense morpholinos results in a loss of
arch cartilage tissue and micrognathia without an increase in
apoptosis, but with a reduction in Phosphohistone-H3 stained nuclei,
indicating a role for barx1 in cellular proliferation and chondrocyte
differentiation. As FGF and BMP signaling are known to pattern arch
development, we examined the inﬂuence of these factors on barx1
expression. Examination of mutant embryos deﬁcient in fgf3 (lia) and
fgf8 (ace), as well as embryos treated with an FGF receptor antagonist
(SU5402), show that FGF signaling is necessary for maintaining and
patterning barx1 expression in the arches. In contrast, ectopic BMP4
signaling induces misspeciﬁcation of barx1 patterning within the
intermediate aspect of the second pharyngeal arch. Thiswork provides
insight into barx1 function and patterning during prechondrogenic
condensation events in the developing zebraﬁsh viscerocranium.
Materials and methods
Animal maintenance and transgenic zebraﬁsh
Zebraﬁsh embryo lines, EKwild-type, ﬂi1:GFP transgenics (Motoike
et al., 2000), and the fgf8/ace mutant, were maintained according to
Westerﬁeld (1995). Fixedwild-type and sibling fgf3/lia embryoswere a
gift from the Hammerschmidt laboratory (Germany). Embryos and
larvae were ﬁxed in 4% paraformaldehyde/phosphate buffered saline
and dehydrated in methanol for storage at −20 °C. FGF inhibition was
performed by soaking 24 hour post-fertilization (hpf) embryos in
10 μm SU5402 (Pﬁzer) in 5% DMSO.
In vitro transcription of synthetic RNA
The zebraﬁsh barx1 (NM001024949) and the barx2 predicted open
reading frame (XM001342008) were ampliﬁed from cDNA produced
by reverse transcription from 96 hpf RNA and cloned into pCRII-TOPO
(Invitrogen). For capped sense mRNA, the barx1 open reading frame
was cloned into pCS2+ plasmid, digested with Not I, and transcribed
with SP6 Polymerase. Capping was performed with 7′ methylguano-
sine GTP analogue cap (NEB).
Attenuation of barx1 expression
Morpholinos (MO) complementary to the translational start site of
barx1 (Bx MO) and the splice acceptor (Sa MO) of the second exon (Fig.
1A) were microinjected into one to two cell-stage embryos. Lissamine
conjugated MOs (Gene-Tools) used are as follows: Bx MO, [5′
CCCCAATCTCCAAAGGATGTTGCAT3′], SaMO [5′GCCTTCAGAACTGGAATG
AAATAAG3′], and a standard control [5′CCTCTTACCTCAGTTA-
CAATTTATA3′]. MOs were diluted in Danieau buffer (58 mM NaCl,
0.7 mMKCl, 0.4mMMgSO4, 0.6mMCa(NO3)2, 5mMHepes, pH 7.6) and
0.01% Phenol Red. Embryoswere injectedwith approximately 1 nl ofMO
at a concentration of 4 ng/nl. For rescue, the MOs were co-injected with
25 ng/μl of barx1mRNA containing ﬁve base pair mismatches within the
ATG MO target site. To test inhibition of translation, a barx1:eGFP fusion
construct was injected together with the MO, and proteins extracted
from24hpf embryoswereblottedwith anti-gfp (1/1000; SantaCruz) and
anti-α-tubulin (1/1000; CalBiochem) antibodies, and detected by a Dura
Chemiluminescence Kit (Pierce). To test the effectiveness of the Sa MO,total RNA was extracted from 24 hpf morphant and control embryos,
DNase I treated and column puriﬁed (Qiagen). RT-PCR, using random
hexamer primers was performed on 1 μg of RNA for each sample
(Superscript III, Invitrogen). Forward (5′-AATGCAACATCCTTTGGAGATT-
3′) and reverse (5′-ATCCCGTTTATTCCTCTTGGTT-3′) primers were used
to test for properly spliced barx1 mRNA. β-actin ampliﬁcation was used
as a control.
Whole-mount in situ hybridization and histological characterization
The following antisense riboprobes were used: chondromodulin
(AF322374) (Sachdev et al., 2001); col2a1 (U23822) (Yan et al., 1995);
crestin (AF195881) (Luo et al., 2001); dlx2a (NM131311) (Akimenko et
al., 1994); dlx2b (NM131297) (Jackman et al., 2004); crestin (Rubinstein
et al., 2000; Luo et al., 2001); goosecoid (gsc) (NM131017) (Stachel et
103S.M. Sperber, I.B. Dawid / Developmental Biology 321 (2008) 101–110al., 1993); hand2 (dhand; NM131626) (Angelo et al., 2000); inca (Luo et
al., 2007); neurod, (NM130978) (Korzh et al., 1998); runx2b
(NM212862) (Flores et al., 2004); and sox9a (NM161343) (Chiang et
al., 2001). Whole-mount in situ hybridizations were performed as
described by Akimenko et al. (1994), using anti-digoxigenin, and anti-
ﬂuorescein antibodies (Roche).
Phosphohistone-H3 antibody (Upstate) was used at 1/1000
dilution, followed by anti-mouse biotinylated secondary antibody
(Vectastain). Cartilage stainingwas performed as in Ellies et al., (1997).
Histological analysis was performed on embryos embedded in JB-4
plastic (Polysciences) and serially sectioned. Sections were stained
with 13% Methylene blue and 0.13% Basic Fuchsin. Apoptosis was
determined by TUNEL labeling, using Terminal Transferase (Roche)
and dUTP-DIG (Roche) as described in Ellies et al. (1997).
Bead implantation
Recombinant BMP4 (1 μg/ml) (R and D Systems) was used with
Afﬁ-Gel Blue beads (Bio-Rad). One percent BSA coated Heparin beads
(Sigma) were used as control. Beads were soaked at 4 °C overnight. A
sharp needle (Fine Instruments) was used to embed beads anterior to
the otic vesicle on the left side of the embryo.
Photography
Samples were digitally photographed with a Leica MZ APO
dissecting microscope connected to a computer running Northern
Eclipse 6.0 image capture software (Empix Imaging Inc.). Live animals
were immobilized with tricaine and mounted in egg water or
methylcellulose. For highermagniﬁcation, ﬁxed embryos were cleared
in glycerol and digitally photographed using a Zeiss Axioplan 2.
Results
Zebraﬁsh barx1 is the orthologue of the mouse and human Barx1 genes
The sequence encoding zebraﬁsh barx1 has recently been
deposited in GenBank (accession no. NM001024949). VertebratesFig. 2. Barx1 expression. Embryos at (A, B) 13 hpf, (C)18 hpf, (D) 19 hpf, (E, F) 24 hpf, (G) 48 hp
in the migrating neural crest in bilateral domains adjacent to the hindbrain (arrows). Ante
expression (arrow). (D) Double in situ of barx1 (dark blue, arrowhead) and crestin (red) co-ex
the cranial neural crest streams. (G, G inset) barx1 expression in the pharyngeal arches and
ventral expression domain; asterisk indicates the a2 intermediate region. (H) Lateral oblique
indicates jaw joint. ch, ceratohyal; ceratobranchials are numbered; e, eye; fb, ﬁn bud; g, gut
pq, palatoquadrate; tr, trabecula. Scale bar: (B and I) 50 μm; (C, E–G) 100 μm.have at least two barx genes, and BLAST-searches of the most recent
version of the zebraﬁsh genome (Zv7), yielded two barx paralogues,
barx1 and a predicted barx2 (XM001342008) located on chromosome
17. The barx1 open reading frame is encoded in four exons and
includes an engrailed homology (EH) domain, the homeobox (HB) and
a conserved Bar Basic Region (BBR, Fig.1A, Supplementary Fig. S1). The
Bar Basic Region is thought to assist in both positive and negative
regulation of downstream genes in a tissue-speciﬁc manner (Edelman
et al., 2000). Similarly, the barx2 sequence indicates a conservation of
the EH, HB and BBR domains. ClustalW alignment and phylogenetic
analysis of the zebraﬁsh, human, mouse and chick Barx proteins
indicate that the zebraﬁsh barx1 gene is closely related to the Barx1
clade (Fig. 1B; Supplementary Fig. S1). The zebraﬁsh barx1 gene,
located on chromosome 11 (DNA contig: CR548622.8; Zv7 genome
assembly; Ensembl release 49, March 2008), exhibits conserved
synteny with human BARX1 located on chromosome 9q22.32
(Ensembl release 49), but not with human BARX2 located on
chromosome 11q24.3 (Hjalt and Murray, 1999), conﬁrming orthology
between the two genes (Fig. 1C).
barx1 expression in the developing zebraﬁsh embryo
In zebraﬁsh, barx1 expression has been previously described and
used as a marker of patterning within the developing pharyngeal
arches (Walker et al., 2006; Walker et al., 2007); however, its
expression pattern has not been fully characterized. To further
understand its role in development, we performed a series of in situ
hybridizations in embryos from the one-cell stage to 120 hour post-
fertilization (hpf) larvae. Transcripts of barx1 were not detected by
RT-PCR or whole-mount in situ hybridization prior to somitogenesis
(data not shown). We observed expression at 9 somites (13 hpf)
during the initiation of rhombencephalic neural crest migration in
bilateral domains on either side of the neural tube (arrows; Figs. 2A,
B). Cells expressing barx1 appear to be a subset of the rhombence-
phalic neural crest, as these cells are located in the most ventral
aspect of the streams compared to the pan-neural crest marker
crestin (ctn, red) (Figs. 2C, D). At 24 hpf, expression was observed in
the three streams of the cranial neural crest, in the gut primordia, ﬁnf, (H) 72 hpf, and (I) 96 hpf, were examined by in situ hybridization. (A) barx1 expression
rior is at the top. (B) Coronal section through the hindbrain. (C) Lateral view of barx1
pression in the neural crest streams indicated by Roman numerals. (E, F) Expression in
ﬁn bud; a1, ﬁrst arch; a2, second arch; d, dorsal expression domain; ga, gill arches; v,
view of barx1 expression in the chondrocytes. (I) Parasagittal section, open arrowhead
primordium; hmc, hyomandibular condensation; M, Meckel3s cartilage; ov, otic vesicle;
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Figs. S2A, B). Trunk and tail expression was progressively lost by
48 hpf (Supplementary Figs. S2A–C). Transcripts in the differentiating
ectomesenchyme of the pharyngeal arches at 48 hpf were concen-
trated in the developing prechondrogenic condensations (Fig. 2G).
Barx1 expression within the dorsal aspect of the second arch
appeared to be rostrally enriched, potentially correlating with sites
of increased proliferation within the hyomandibular condensation
that subsequently fuses with the symplectic element (Kimmel et al.,
1998). Expression was also maintained in the pectoral ﬁn bud (Fig.
2G, inset). In mammals, Barx1 participates in tooth development
(Tucker et al., 1998; Song et al., 2006; Mitsiadis and Drouin, 2008).Fig. 3. Attenuation of barx1 expressionperturbs viscerocranial morphology and cartilage patte
staining of control MO (D) and Bx MO injected (E and F) 120 hpf larvae. Dissection of the ﬁr
sections of 72 hpf embryos. (J) Bx MO (4 ng) injected compared with (I) control MO injected
indicate mouth, and arrowheads the pharyngeal arches; (D–F) open arrowheads indicate th
betweenMeckel's cartilage (M) and the palatoquadrate (pq); cb, ceratobranchials; ch, ceratoh
bars: (A–C) 250 μm; (D–H) 100 μm; (J) 50 μm. (K, L) Effectiveness and speciﬁcity of the barx1
barx1:GFP translation in 24 hpf zebraﬁsh embryos. (L) Total RNA extracts (18S and 28S band
embryos comparing control MO, Bx MO and Sa MO, and rescue by co-injection of barx1 mRN
exhibitingmicrognathia as a result of a reduction or loss of arch cartilage elements, as seen by
MO 2 ng+Sa MO 2 ng. Rescue: (5) gfp mRNA 25 pg; (6) barx1 mRNA 25 pg; (7) Bx MO+Sa MWe examined whether barx1 is expressed in the developing tooth
buds at 56 hpf, a time when tooth primordia are readily observable
(Jackman et al., 2004) (asterisk, Supplementary Fig. S2D). Expression
of barx1 appears to be adjacent to the condensing tooth bud
primordia. In 72 hpf embryos, barx1 continued to be expressed for
the most part in the stacked arrays of chondrogenic cells, but
diminishes as the elements mature (Fig. 2H and data not shown). At
this time, we also identiﬁed barx1 expression in the posterior lateral
line ganglia (pllg, Supplementary Figs. S2E, F, H, H inset). Transcripts
of barx1 continued to be detected in the intestinal wall of the gut
(Supplementary Figs. S2H, I). By 96 hpf, serial sections of larvae
showed a progressive loss of barx1 expression in the stackedrning. Larvae injectedwith (A) controlMO (4 ng), and (B and C) BxMO (4 ng). Alcian Blue
st and second arches of control (G) and mildly affected larvae (H). (I and J) Parasagittal
(4 ng). Anterior is to the left; (A–C, G–J) lateral views, (D–F) ventral view. (A–C) Arrows
e ceratohyal cartilage; (G, H) asterisk, perturbed fusion; black arrowhead, joint fusion
yal; ep, ethmoid plate; hm, hyomandibular; ov, otic vesicle; sy, symplectic element. Scale
(Bx) and splice-acceptor (Sa) morpholinos. (K) Western analysis of in vivo attenuation of
s shown) used for RT-PCR of barx1. β-actin used as a control. (M) Percentage of affected
A with a 5-bp mismatch to the ATG target site. Affected embryos are deﬁned as those
Alcian Blue staining at 120 hpf. (1) ControlMO4 ng; (2) BxMO 4 ng; (3) SaMO 4 ng; (4) Bx
O 2 ng each+barx1 mRNA 25 pg. Number of embryos indicated on top of each bar.
Fig. 4. Initial patterning of the arches is maintained in barx1 morphants. (A, C, E and G)
Control MO-injected embryos, (B, D, F and H) embryos co-injected with Bx MO+Sa MO,
2 ng each. Neural crest expression of inca (A, B) and dlx2a (C and D) at 24 hpf. (E, F)
neurod expression at 24 hpf in neural ganglia precursors; (G and H) hand2 expression in
ventral endoderm at 32 hpf. Neural crest streams marked in Roman numerals, gill
arches indicated by numbers; e, eye; m, mandibular arch; h, hyoid arch; ov, otic vesicle;
ad/av/f, anterodorsal/anteroventral lateral line/facial placode/ganglia; o, octavel/
statoacoustic ganglia precursors; p, posterior lateral line placode/ganglion. Scale bar:
100 μm.
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mesenchyme (Fig. 2I). In summary, expression in the head skeleton
was restricted to the ectomesenchyme of the developing pharyngeal
arches up to 120 hpf, and was not observed in the neurocranium.
To determine whether there might be genetic redundancy
between barx1 and barx2, we examined the expression pattern of
the barx2 paralogue (Supplementary Fig. S3). In contrast to barx1,
barx2 is expressed in the proximal aspect of the pectoral ﬁn buds from
24 to 32 hpf (Supplementary Figs. S3A–C). From 36 hpf to 72 hpf,
expression is observed in the oral and aboral epithelium of the
mandibular and hyoid arches (Supplementary Figs. S3D–H), and not in
the condensing mesenchyme of the chondrogenic elements (arrow-
heads, Supplementary Fig. S3G). Expression is also observed in the
olfactory epithelium (Supplementary Fig. S3F inset). The expression
patterns of barx1 and barx2 do not overlap in the condensing
mesenchyme of the prechondrogenic elements, suggesting that
limited or no genetic redundancy exists between the paralogues.
barx1 is necessary for pharyngeal arch chondrogenesis
To determine the role of barx1 in the developing pharyngeal arches
and viscerocranium, we used antisense morpholinos (MO) targeted to
the ATG site (Bx MO) and a splice-acceptor site (Sa MO) (Fig. 1A). MOs
were injected into 1–2 cell embryos, and development was followed
to 120 hpf. Compared to control MO-injected larvae at 120 hpf,
morphants exhibited reduction in head size ranging from mild to
severe hypoplastic pharyngeal arch morphology exempliﬁed by
micro- or agnathia (Figs. 3A–C, arrow), due to poor pharyngeal arch
outgrowth (open arrowhead, Figs. 3A–C). Alcian Blue staining showed
reductions or a lack of pharyngeal arch-derived chondrogenic
elements (Figs. 3D–F). Generally, all the elements were dysmorphic,
while the ceratobranchial elements were the most likely to be lost,
which included the ﬁfth arch elements containing the pharyngeal
teeth. The most severely affected larvae exhibited either small
cartilage nodules in place of elements or lacked any cartilage in the
viscerocranium (open arrowhead, Fig. 3F, and data not shown). In
more mildly affected larvae, reductions in chondrocyte condensation
and incomplete fusions were observed between the symplectic and
the hyomandibular elements (asterisk, Figs. 3G, H), as well as
abnormal joint fusions between Meckel's cartilage and the palatoqua-
drate element (black arrowhead, Figs. 3G, H). Histological examination
of larvae at 72 hpf during cartilage condensation in the pharyngeal
arches showed a lack of cellular organization within the arches, as
shown by a deﬁciency of prechondrocyte aggregation and absence of
characteristic extracellular matrix surrounding the cells (arrow, Figs.
3I, J; see also boxed region in Supplementary Figs. S4A, B).
To test the effectiveness of the Bx MO, a barx1:GFP fusion mRNA
containing the ATG MO target site was co-injected with the
morpholino into 1–2 cell embryos. Western blot analysis at 24 hpf
showed that the morpholino effectively inhibited barx1:GFP transla-
tion indicating that injected embryos are strong hypomorphs (Fig. 3K).
Additionally, to verify that the phenotype was due to the attenuation
of barx1 translation, the second MO targeting the second exon splice-
acceptor site was tested (Sa MO; Fig. 1A). RT-PCR of Sa MO-injected
embryo RNA extracts showed a reduced amount of product of spliced
mRNAs when compared to control embryos (Fig. 3L). Embryos
injected with 4 ng of Bx MO or the Sa MO exhibited identical
phenotypes of dysmorphic viscerocranial patterning at similar
frequencies (Fig. 3M, bars 2 and 3). Co-injection of both Bx MO and
Sa MO (2 ng each) produced the same phenotype with a higher
effectiveness (Fig. 3M, bar 4). Finally, rescue of the phenotype was
achieved by co-injecting both morpholinos with barx1mRNA contain-
ing a 5-base pair mismatch in the ATG target sequence (Fig. 3M, bar 7).
Injection of 25 pg mRNA, used for rescue, was not deleterious, but
higher doses (50 pg) of mRNA caused most embryos to exhibit
aberrant gastrulation.barx1 is not required for early neural crest speciﬁcation
To test whether barx1 participates in speciﬁcation of the
prechondrocyte lineage, we examined cranial neural crest markers
expressed in the migrating cells in barx1 morphants. Molecular
markers of the cranial neural crest (see Materials and methods) that
include inca (Figs. 4A, B), dlx2a (Figs. 4C, D), as well as neurod, a
marker of nascent ganglion cells (Figs. 4E, F), and hand2, an
endodermal marker, were tested (Figs. 4G, H). In all cases, expression
patterns of these markers in barx1 morpholino-injected embryos
appeared normal at 24 hpf, although development of the injected
embryos appeared mildly delayed. This suggests that a deﬁciency in
barx1 expression does not strongly affect speciﬁcation and migration
of the hindbrain-derived neural crest. Likewise, examination of ﬂi1:
GFP barx1 morpholino-injected embryos that express GFP in the
pharyngeal arches (Lawson and Weinstein, 2002; Crump et al., 2004),
suggested that neural crest migration into the arches is normal
(Supplementary Figs. S4C–F).
Pharyngeal arch chondrocyte differentiation requires barx1
To determine the role of barx1 in cartilage patterning, we examined
markers of differentiation of osteochondroprogenitor cells in MO-
injected embryos. The expression patterns examined included goosecoid
(gsc), a marker of cellular condensation in the hyoid arch (Schulte-
Merker et al., 1994); sox9a, a transcription factor necessary for
chondrogenesis (Yan et al., 2002; Yan et al., 2005); runx2b, a marker of
mesenchymal condensations and chondrocyte differentiation (Flores et
al., 2006); ﬁbril-forming type II collagen (col2a1), the major component
of the cartilage extracellular matrix (Yan et al., 1995), chondromodulin
(chm), a secreted glycoprotein that stimulates maturation of chondro-
cytes and inhibits vascularization (Sachdev et al., 2001); and dlx2b, a
marker of tooth differentiation on the ﬁfth ceratobranchial arch
(Jackman et al., 2004) (Fig. 5). While the heads of barx1 morphants
were reduced in size compared to controls, gsc and sox9a expression
Fig. 6. Loss of barx1 enhances chordin and gdf5 expression in the jaw joint. Whole-
mount in situ hybridization for (A, B) bapx1, (C, D) chordin (chd), and (E, F) gdf5. (A, C, E)
Control uninjected embryos; (B, D, F) barx1 morphants (see Fig. 4). Embryonic ages as
indicated. (A, B) Lateral view, anterior to the left. (C–F) Ventral view, anterior at the top;
asterisk indicates Meckel's cartilage, open arrowheads indicate jaw joint expression
domains; e, eye; ch, ceratohyal; o oriﬁce. Scale bar: (A–F) 50 μm.
Fig. 5. Barx1 is necessary for expression of chondrogenic markers within the
pharyngeal arches. (A, C, E, G, I and K) Control embryos; (B, D, F, H, J and L) barx1
morphant embryos (see Fig. 4). Whole-mount in situ hybridization for (A, B) goosecoid
(gsc), (C, D) sox9a, (E, F) runx2b, (G, H) type II collagen (col2a1), (I, J) chondromodulin
(chm), and (K, L) dlx2b. Anterior is to the left; open arrowheads indicate sites of altered
marker expression in the morphants; bcc, basicranial commissures; cb, ceratobran-
chials; ch, ceratohyal; cl, cleithrum; d, diencephalon; ep, ethmoid plate; fb, ﬁn bud;
hsc, hyosymplectic condensation; ov, otic vesicle; pq, palatoquadrate; t, telencephalon.
Scale bar: 100 μm.
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expression may be regulated independently of barx1 (Figs. 5A–D).
However, molecular markers of the chondrogenic and subsequent
osteogenic program, col2a1, chm, and runx2b, were reduced or lost (Figs.
5E–J). In addition to theperturbation of the osteochondrogenic program,
morphants showed a loss of dlx2b expression, suggesting that tooth
development was also affected (Figs. 5K, L). Further examination of
histological sections of 120 hpf barx1morphant larvae (n=2/5) showed
condensation of tooth germs at an early cytodifferentiation stage of
development whereas control larvae (n=3/3) exhibited erupted teeth
(Supplementary Fig. S5). These data point to the importance of Barx1
function during the earliest stages of chondrogenesis.Attenuation of barx1 enhances markers of jaw joint patterning
Morphants stained with Alcian Blue exhibited a range of altered
cartilage morphology that included mispatterning of the joints (Figs.
3D–H). Barx1 is expressed in the mouse and chick joints of the
limbs and digits and has been suggested to regulate joint patterning
by inhibiting chondrogenesis in limb micromass cultures (Tissier-
Seta et al., 1995; Church et al., 2005). To determine the inﬂuence of
barx1 on joint patterning within the viscerocranium, we examined
between 48 and 80 hpf molecular markers, bapx1, chordin, and gdf5,
which are expressed in the developing jaw joint (Miller et al., 2003).
Expression of bapx1 at 48 hpf (Figs. 6A, B) and 56 hpf (data not
shown), showed no to perhaps a mild enhancement in expression in
morphant embryos. However, expression patterns of chordin as well
as gdf5 were noticeably enhanced within the jaw joint by the loss of
barx1 (open arrowheads, Figs. 6C–F). These results suggest that
barx1 inﬂuences the regulation of these two genes necessary for the
proper patterning of the jaw joint in zebraﬁsh.
barx1 is necessary for cellular proliferation of chondrogenic progenitors
We examined the effect of loss of barx1 function on cell death
and proliferation within the migrating neural crest streams and the
pharyngeal arches. Control and barx1 morphant embryos during
migration and pharyngogenesis (13, 24 and 48 hpf) showed no
apparent increase in apoptosis as determined by TUNEL labeling
(data not shown). The hypoplastic arches suggested that barx1 might
participate in cellular proliferation. The pharyngeal arch mesench-
yme was examined in serially sectioned control and barx1
morphants stained with Phosphohistone-H3 (PH3) antibody at 34,
48, 56, and 72 hpf, a period of prominent arch outgrowth. Stained
nuclei were counted within the arch ectomesenchyme, as indicated
by the light green overlay marking the region of interest in Figs. 7A,
B, in approximately 50 sections per embryo. The results show that
barx1 morphants exhibited 1.5 to 2.5-fold fewer dividing cells in
the mesenchymal regions than control embryos at 48 and 56 hpf,
Fig. 8. Barx1 expression in fgf mutant embryos. (A, B) Wild-type sibling and lia/fgf3
mutant. Arrows indicate sites of barx1 expression in the gill arches. (C–E) Wild-type
sibling and left and right views of an ace/fgf8 mutant embryo. Left/right asymmetric
expression indicated in the mutant (arrowhead); asterisk indicates reduced expression
in the third gill arch. (F, G) Overstained control (DMSO) and embryo treated with the
FGF receptor inhibitor SU5402 from 24 hpf to 48 hpf. Lateral views with anterior to the
left, panel D was ﬂipped for comparison; d, dorsal and v, ventral expression domains of
the second arch; e, eye; gill arches are numbered; g, gut primordium; h, hyoid arch; m,
mandibular arch; ov, otic vesicle. Scale bar: (A–G) 50 μm.
Fig. 7. Barx1 positively inﬂuences cellular proliferationwithin the pharyngeal arches. (A,
B) Sagittal serial sections (10 μm) of the pharyngeal arch region stained with
Phosphohistone-H3 antibody. (A) Control embryo at 48 hpf. (B) barx1 morphant. The
neural crest derived mesenchyme is overlaid in green; arrows indicate stained nuclei; e,
eye; m, mandibular arch; h, hyoid arch; gill arches are numbered. Anterior is to the left.
Scale bar: 50 μm. (C) Averaged cell proliferation in control uninjected embryos (black
bars) and barx1 morphants (see Fig. 4; white bars) was determined within the
mesenchyme as shown in panels A, B at the indicated four time points. Approximately
ﬁfty serial sections per embryo were examined. Number of embryos examined is
indicated above each bar. Scale bar: (A, B) 50 μm.
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decrease in PH3 labeled nuclei within the pharyngeal arch
mesenchyme is at a critical period of arch outgrowth, our data
suggest that barx1 is involved in proliferation of the arch
osteochondrogenic progenitors.
FGF signaling is necessary for barx1 expression in the pharyngeal arches
FGF signaling is required for proper pharyngeal arch patterning
(Abu-Issa et al., 2002; David et al., 2002; Frank et al., 2002; Trokovic
et al., 2003; Walshe and Mason, 2003; Crump et al., 2004; Trokovic et
al., 2005). In chick and mouse, FGFs emanating from the oral
ectoderm positively inﬂuence the underlying Barx1 mesenchymal
expression of the ﬁrst arch (Tucker et al., 1998; Barlow et al., 1999). In
zebraﬁsh, fgf8 and fgf3 are expressed in the pharyngeal arch
endoderm (Walshe and Mason, 2003). To determine the inﬂuence
of FGF signaling on barx1 expression in zebraﬁsh, we examined the
fgf3 (lia) and the fgf8 (ace) mutants. In fgf3 mutants, larvae exhibit
malformed mandibular and hyoid derived cartilages, and lack more
posterior cartilages in the gill arches (Crump et al., 2004; Herzog et
al., 2004). Expression of barx1 was similarly affected in thattranscripts were detected in the anterior arches but were reduced
or lacking in the gill arches (arrows, Figs. 8A, B).
In fgf8 mutants, left/right asymmetries were previously observed
in pharyngeal arch cartilage patterning (Albertson and Yelick, 2005).
Therefore, using barx1 as a marker of chondrocyte condensation, we
examined ace mutants for differences between control embryos and
Fig. 9. Exogenous BMP signaling inﬂuences barx1 expression within the zebraﬁsh
pharyngeal arches. (A, B) Whole-mount in situ hybridization of barx1 in the left (bead
implanted) and right (control) side of single embryos. Right-side images were ﬂipped
for easier comparison. (A, A′) Control BSAwhite bead, (B, B′) BMP4 blue bead. Anterior is
to the left; d and v, dorsal and ventral expression domains in the second arch; e, eye.
Arrowhead indicates sites of barx1 misexpression; asterisk indicates intermediate
region, normally devoid of barx1 expression at this stage. Number of affected embryos
over total embryos with successful bead implantation is indicated in the panels A, B.
Black dashed line outlines the bead. Scale bar: 50 μm.
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differences were observed in the cellular condensation within the
stacked arrays on the two sides of the same embryo in ace mutants
(Figs. 8C–E); the differences included reduced (black arrowheads) or
absence of barx1 expression (asterisk). As multiple FGF ligands are
expressed in the embryo, we blocked all FGF receptor signaling with
the pharmacological inhibitor SU5402 (Mohammadi et al., 1997).
Embryos soaked in the inhibitor beginning at 24 hpf and compared to
control siblings at 48 hpf lose barx1 expression (Figs. 8F, G). These data
indicate that FGF signaling is necessary for maintaining barx1
expression in the arches and suggests that several FGF ligands are
involved in this process.
barx1 is inﬂuenced by exogenous BMP4 signaling within the hyoid arch
intermediate zone
Signaling factors that include BMPs emanating from the encapsu-
lating tissues are necessary for patterning the pharyngeal arches and
inﬂuencing subsequent chondrogenesis (Hall and Miyake, 2000;
Helms and Schneider, 2003; Goldring et al., 2006; Nie et al., 2006b).
We examined the effects of exogenous BMP4 signaling on barx1
expression. The effectiveness of using beads coated in BMPs has
previously been demonstrated in chick and mouse organ cultures as
well as in zebraﬁsh embryos (Barlow and Francis-West, 1997; Tucker
et al., 1998; Holzschuh et al., 2005). Beads were implanted on the left
side at 24 hpf and the embryos were allowed to develop until 48 hpf.
Control embryos were implanted with beads coated in 1% BSA (Figs.
9A, A′), and exhibited identical barx1 expression on their left and
right-hand sides (n=17/17). Embryos implanted with BMP4 coated
beads expressed barx1 within the intermediate domain of the second
(hyoid) arch, where expression is not normally observed (open
arrowhead in Figs. 9B, B′; n=4/7). Embryos implanted with BMP4
(n=11) beads at 36 hpf and examined at 60 hpf did not show any
difference in barx1 expression compared to the control side (data not
shown). These observations indicate that BMP4 can lead to ectopic
barx1 expression within the hyoid intermediate zone with a regional
and time-dependent speciﬁcity in the response.
Discussion
Endochondral bone formation is preceded by chondrogenesis that
forms the anlage for shaping of the bones (Hall and Miyake, 2000;Karsenty and Wagner, 2002; Goldring et al., 2006). The viscerocra-
nium consists of highly adapted skeletal elements necessary for
mastication, auditory ampliﬁcation, and vocalization (Sperber and
Sperber, 1996). How these elements are patterned is not well
understood. Here we report analysis of the zebraﬁsh barx1 transcrip-
tion factor expression, its functional role in patterning chondrocyte
condensation within the pharyngeal arches and the inﬂuence of
morphogenic cues on its expression. Our experiments indicate that
zebraﬁsh barx1 is essential for proper patterning of the osteochon-
drogenic progenitors within the pharyngeal arches.
Zebraﬁsh barx1
We have characterized the zebraﬁsh barx1 gene and compared it to
its paralogue, barx2. The expression of barx1 in the zebraﬁsh embryo
shows both conserved and divergent patterns compared to the mouse
and chick. In the mouse, Barx1 is expressed in the mesenchyme of the
maxillary facial prominences, restricted in the ﬁrst and second arches
to the lateral aspects abutting the stomodeum and the pharyngeal
cavity, and is prominently found in the molar ﬁeld, yet lacking in
Meckel's cartilage condensations (Tissier-Seta et al., 1995). Expression
is also observed in the mouse olfactory epithelium. In chick, Barx1 is
expressed in the mesenchyme and the epithelium of the facial
primordia and is detected after neural crest migration into the arches
(Barlow et al., 1999). Barx genes further are expressed in articular
cartilage and the epiphyseal growth plate (Tissier-Seta et al., 1995;
Barlow et al., 1999; Church et al., 2005; Meech et al., 2005). In contrast,
zebraﬁsh barx1 expression is detected early in the migrating
hindbrain-derived neural crest and subsequently throughout the
pharyngeal arch mesenchyme. As chondrogenesis progresses, barx1
expression is downregulated in arrayed cells (Fig. 2I) while being
maintained in the surrounding mesenchyme, suggesting that loss of
barx1 expression may be a prerequisite for osteogenic differentiation.
Barx1 expression was not detected in the ethmoid plate or trabeculae
of the neurocranium, even though midbrain–hindbrain neural crest
contributes to these structures, which undergo endochondral bone
formation (Eberhart et al., 2006). These observations illustrate genetic
differences in the chondrogenic program of neural crest cells derived
from a similar location undergoing condensation within different
elements of the chondrocranium. In comparison, barx2 is expressed
most prominently in the oral and aboral epithelium of the ﬁrst and
second arches as well as in the olfactory epithelium, but not in the gut,
and is thereforedivergent of the observedpattern inhigher vertebrates
(Tissier-Seta et al., 1995; Barlow et al., 1999; Sander and Powell, 2004).
Comparison of these patterns suggests that an alternate evolutionary
subfunctionalization of the barx genes has occurred in teleosts in
contrast to higher vertebrate model systems. Barx1 expression was
also conserved in the developing gut wall in zebraﬁsh as in the mouse
and chick, aswell as in the pectoral ﬁn/limb buds. Transient expression
was detected in the posterior lateral line ganglia at 72 hpf. Additional
transient expression from 24 to 32 hpf was observed in the somite
chevrons of the trunk and tail.
Initial arch patterning is maintained in barx1 morphants
The loss of barx1 function does not affect the speciﬁcation of the
cranial neural crest or the initial patterning of the pharyngeal arches as
expression of neural crest markers dlx2a and inca is maintained during
migration in barx1 morphants. Initial arch patterning appears normal
as the pouches formwhenvisualized in the ﬂi1:GFP transgenic line. The
behavior of other derivatives of the neural crest, such as aspects of the
facial ganglia, which express neuroD andmelanophores responsible for
pigment, indicate that their respective differentiation is maintained in
the morphants. As development progresses, however, we observed
dysmorphogenesis within the pouches, presumably because of
reduced cellular proliferation and compromised cellular condensation.
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Two phases have been recognized in cartilagemorphogenesis of the
zebraﬁsh pharyngeal arches, deposition of matrix by condensed
chondrocytes, and a period of rapid growth (Kimmel et al., 1998).
Barx genes regulate the cell adhesion molecule NCAM (Hirsch et al.,
1991; Edelman et al., 2000), which is expressed in aggregating
prechondrocytes (Widelitz et al., 1993; DeLise et al., 2000; Hall and
Miyake, 2000), and theﬁbril-forming type II collagen (Col2a1), themain
component of cartilage extracellular matrix (Meech et al., 2005). Here
we show that attenuation of barx1 resulted in poor facial outgrowth
due to fewer chondrocytes and poor deposition of matrix, causing
dysmorphic cartilage elements as shown by poor fusion between the
symplectic and hyomandibular elements (Fig. 3H). We observed that
barx1 morphants cause the perturbation of osteogenic promoting
factors that include runx2b and chondromodulin (Fig. 5). Additionally,
factors co-expressed in the arch neural crest, dlx2a and sox9a, which
are required for chondrogenesis maintain their expression in the barx1
morphants. These observations suggest that barx1 functions at the
earliest stages of prechondrocyte aggregation in an apparently
independent regulatory mechanism compared to other cartilage and
bone associated transcription factors.We further observed an enhance-
ment in chordin and gdf5 expressionwithin the jaw joint of morphants.
Meech et al. (2005) showed that Gdf5 is able to induce Barx2
expression, suggesting a functional connection. Here we show that
the loss of the barx1 induces gdf5 expression, suggesting a potential
negative feedback regulatory mechanism that may function to balance
their respective roles in chondrogenesis and joint patterning.
FGF and BMP signaling inﬂuence barx1 expression in the pharyngeal
arches
Reciprocal epithelial–mesenchymal interactions mediated by BMPs
are essential for pharyngeal arch patterning and chondrogenesis (Tucker
et al.,1998; Barlowet al.,1999; Tucker et al.,1999;Mina et al., 2002;Nie et
al., 2006b). During chondrogenesis, FGF and BMP signaling is thought to
act antagonistically, balancing proliferation and terminal differentiation
in a complex regulatory network (Minina et al., 2002;Ornitz, 2005;Nie et
al., 2006a; Nie et al., 2006b). In higher vertebrates, FGF8 and BMP2/4
induce and negatively inﬂuence Barx1 expression, respectively, in the
maxillary andmandibular prominences (Tucker et al.,1998; Barlow et al.,
1999). Conversely, in limb cultures, BMP4 positively inﬂuences Barx2
expression (Meech et al., 2005). Fgf8 and Fgf3 emanating from the
endoderm, participate in the segmentation of the arches in zebraﬁsh by
promoting neural crest survival and cellular proliferation (Walshe and
Mason, 2003; Crumpet al., 2004). In our report, fgf3 and fgf8deﬁcientﬁsh
perturb but do not abolish barx1 expression. However, incubation with
SU5402, a FGF receptor antagonist, completely abolishes barx1 expres-
sion. These data suggest that multiple FGFs are necessary to regulate and
maintain barx1 expression in an apparent coordinate manner.
BMP signaling is involved at different stages of the chondrogenic
program (Yoon and Lyons, 2004), and BMPs emanate from the pouch
endoderm of the zebraﬁsh arches (Holzschuh et al., 2005). BMP2/4
beads implanted in the chick mandible show loss of surrounding
Barx1 expression (Tucker et al., 1998; Barlow et al., 1999). However, we
observed that BMP4 bead implantation induced ectopic barx1
expression within the receptive cells of the second arch intermediate
region. Taken together, these reports and our data suggest that barx1
expression inﬂuenced by BMP cues reﬂect the cellular proliferation
and extracellular matrix production necessary for shaping of cartilage
elements within the viscerocranium.
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